The treatment of precocious puberty

M. D. Wheeler; D. M. Styne

doi:10.1016/s0889-8529(18)30287-1

The treatment of precocious puberty

M. D. Wheeler, D. M. Styne

Pediatrics

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Abstract

Long-acting GnRH agonists are the treatment of choice for central precocious puberty. GnRH agonists are not effective in peripheral precocious puberty, but a number of other agents, including medroxyprogesterone acetate, ketoconazole, testolactone, and androgen antagonists, may be useful.

Original language	English (US)
Pages (from-to)	183-190
Number of pages	8
Journal	Endocrinology and Metabolism Clinics of North America
Volume	20
Issue number	1
DOIs	https://doi.org/10.1016/s0889-8529(18)30287-1
State	Published - 1991

ASJC Scopus subject areas

Endocrinology, Diabetes and Metabolism
Endocrinology

Access to Document

10.1016/s0889-8529(18)30287-1

Cite this

@article{d9ccf4c7c9e943d992282e81d43333c9,

title = "The treatment of precocious puberty",

abstract = "Long-acting GnRH agonists are the treatment of choice for central precocious puberty. GnRH agonists are not effective in peripheral precocious puberty, but a number of other agents, including medroxyprogesterone acetate, ketoconazole, testolactone, and androgen antagonists, may be useful.",

author = "Wheeler, {M. D.} and Styne, {D. M.}",

year = "1991",

doi = "10.1016/s0889-8529(18)30287-1",

language = "English (US)",

volume = "20",

pages = "183--190",

journal = "Endocrinology and Metabolism Clinics of North America",

issn = "0889-8529",

publisher = "W.B. Saunders",

number = "1",

}

TY - JOUR

T1 - The treatment of precocious puberty

AU - Wheeler, M. D.

AU - Styne, D. M.

PY - 1991

Y1 - 1991

N2 - Long-acting GnRH agonists are the treatment of choice for central precocious puberty. GnRH agonists are not effective in peripheral precocious puberty, but a number of other agents, including medroxyprogesterone acetate, ketoconazole, testolactone, and androgen antagonists, may be useful.

AB - Long-acting GnRH agonists are the treatment of choice for central precocious puberty. GnRH agonists are not effective in peripheral precocious puberty, but a number of other agents, including medroxyprogesterone acetate, ketoconazole, testolactone, and androgen antagonists, may be useful.

UR - http://www.scopus.com/inward/record.url?scp=0025843461&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025843461&partnerID=8YFLogxK

U2 - 10.1016/s0889-8529(18)30287-1

DO - 10.1016/s0889-8529(18)30287-1

M3 - Article

C2 - 1827623

AN - SCOPUS:0025843461

SN - 0889-8529

VL - 20

SP - 183

EP - 190

JO - Endocrinology and Metabolism Clinics of North America

JF - Endocrinology and Metabolism Clinics of North America

IS - 1

ER -

The treatment of precocious puberty

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this